https://doi.org/
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
208
 
downloads
29
CITE
How to cite this poster:
Bhardwaj N, Merad M, Kim-Schulze S et al. Flt3L-primed _in situ_ vaccine for patients with low-grade lymphoma: tumor regression at untreated sites (NCT01976585). F1000Posters 2014, 5:1871 (poster)

Flt3L-primed in situ vaccine for patients with low-grade lymphoma: tumor regression at untreated sites (NCT01976585)

Nina Bhardwaj, Miriam Merad, Seunghee Kim-Schulze, Elizabeth Crowley, Tibor Keler, Thomas Davis, Joshua Brody1
Published 17 Dec 2014
Author Affiliations
  • Metrics
  • 208 Views
  • 29 Downloads
 
Browse by related subjects
Published 17 Dec 2014

Flt3L-primed in situ vaccine for patients with low-grade lymphoma: tumor regression at untreated sites (NCT01976585)

[version 1; not peer reviewed]

Nina Bhardwaj, Miriam Merad, Seunghee Kim-Schulze, Elizabeth Crowley, Tibor Keler, Thomas Davis, Joshua Brody1
Author Affiliations
1 Medicine, Mount Sinai School of Medicine, USA
Presented at
Society for Immunotherapy of Cancer (SITC) Meeting 2014
Abstract
Competing Interests

No competing interests were disclosed

Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.